Advanced Wound Care Technologies Boost DFU Treatment Demand
The Europe diabetic foot ulcer (DFU) market is set to grow significantly, from an estimated USD 1.84 billion in 2022 to nearly USD 2.9 billion by 2030. This expansion is driven by the increasing incidence of diabetes, aging populations, growing adoption of advanced wound care therapies, and an ongoing shift toward home-based healthcare solutions. Diabetic foot ulcers affect more than 30% of diabetic individuals at some point in their lives and are one of the leading causes of lower-limb amputation. The combination of neuropathy, poor circulation, and delayed wound healing requires a coordinated approach to management, making advanced and accessible care solutions critical across the European region. To Get Free Sample Report: https://www.datamintelligence.com/download-sample/europe-diabetic-foot-ulcers-market Key Market Drivers Rising Diabetes and Geriatric Population Diabetes affects over 60 million people in Europe, many of whom are over 60. The geriatric population is especi...